(1) The Drug Management Review Advisory Board shall coordinate the use of utilization data to identify appropriate use of pharmaceuticals and determine any need for educational interventions. Prospective drug utilization review and retrospective drug utilization review measures shall be utilized to monitor the success of the interventions. Interventions shall be evaluated for a period of not less than six (6) months.
(2) Implementation and performance of the duties of this section and KRS § 205.5631,

Ask a legal question, get an answer ASAP!
Click here to chat with a lawyer about your rights.


205.5632, and 205.5636 and any drug review shall be performed by the staff of the
Cabinet for Health and Family Services, or its contractors.
Effective: June 20, 2005
History: Amended 2005 Ky. Acts ch. 99, sec. 237, effective June 20, 2005. — Amended
2002 Ky. Acts ch. 7, sec. 4, effective February 21, 2002. — Created 1998 Ky. Acts ch. 561, sec. 3, effective July 15, 1998.